Patent · US Active

Alzheimer Aβ peptide binding polypeptide

US11098096B2 · kind B2 · utility

0Cited by

2References

14Claims

0Family size

Assignee

AMYLONIX AB · SE

Inventors

Stefan Ståhl · Stockholm, SE
John Löfblom · Huddinge, SE
Hanna Lindberg · Stockholm, SE
Torleif Härd · Uppsala, SE

Key dates

Filing date	Dec 16, 2019
Grant date	Aug 24, 2021
Priority date	—
Expiry date	Dec 16, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to a class of engineered polypeptides having a binding affinity for amyloid β (Aβ) peptides (in the following referred to as Aβ), comprising the amino acid sequence EX2X3YX5X6NLX9A X11QLCAX16IX18X19X20 ED (SEQ ID NO:632). The present disclosure also relates to the use of such Aβ peptide binding polypeptides as therapeutic, prognostic and/or diagnostic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.